This is the authors' abstract. We don't add key points for this paper.
This meta-analysis showed that BL/BLIs may be promising alternative antibiotics for definitive therapy in patients with ESBL-B. However, the lack of robust data derived from randomized controlled trials limits the conclusions and inferences from the pooled data.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Son et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: